
Tuesday, March 27, 2018 9:37:22 PM
Recent XOMA News
- ESSA Pharma Inc. Announces Definitive Agreement to be Acquired by XenoTherapeutics, Inc., Backed by XOMA Royalty Corporation in All-Cash Transaction • PR Newswire (US) • 07/14/2025 12:00:00 PM
- ESSA Pharma Inc. Announces Definitive Agreement to be Acquired by XenoTherapeutics, Inc., Backed by XOMA Royalty Corporation in All-Cash Transaction • PR Newswire (Canada) • 07/14/2025 12:00:00 PM
- Turnstone Biologics Corp. Enters into Agreement to be Acquired by XOMA Royalty Corporation for $0.34 in Cash Per Share Plus a Contingent Value Right • GlobeNewswire Inc. • 06/27/2025 11:30:00 AM
- XOMA Royalty Declares Quarterly Preferred Stock Dividends • GlobeNewswire Inc. • 06/18/2025 11:30:00 AM
- XOMA Royalty Purchases Mezagitamab Royalty and Milestone Rights Held by BioInvent International for up to USD $30 Million • GlobeNewswire Inc. • 05/27/2025 12:01:00 PM
- XOMA Royalty Reports First Quarter 2025 Financial Results and Highlights Business Achievements • GlobeNewswire Inc. • 05/13/2025 11:30:00 AM
- XOMA Royalty to Present at H.C. Wainwright 1st Annual Royalty Company Virtual Conference • GlobeNewswire Inc. • 05/07/2025 11:30:00 AM
- XOMA Royalty Completes Sale of Kinnate Pipeline Assets • GlobeNewswire Inc. • 04/14/2025 11:30:00 AM
- XOMA Royalty to Present at Jones Healthcare and Technology Innovation Conference • GlobeNewswire Inc. • 04/02/2025 11:30:00 AM
- XOMA Royalty Declares Quarterly Preferred Stock Dividends • GlobeNewswire Inc. • 03/20/2025 11:30:00 AM
- XOMA Royalty Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Business Achievements • GlobeNewswire Inc. • 03/17/2025 08:30:00 PM
- XOMA Royalty to Present at Investor Conferences in March • GlobeNewswire Inc. • 02/24/2025 09:05:00 PM
- XOMA Royalty to Present at Oppenheimer 35th Annual Healthcare Life Sciences Conference • GlobeNewswire Inc. • 02/04/2025 12:30:00 PM
- XOMA Royalty Declares Quarterly Preferred Stock Dividends • GlobeNewswire Inc. • 12/19/2024 12:30:00 PM
- XOMA Royalty Acquires Pulmokine for $20 Million Adding the Royalty and Milestone Interest in Seralutinib, a Phase 3 Asset, to Its Portfolio • GlobeNewswire Inc. • 12/02/2024 12:30:00 PM
- XOMA Royalty Reports Third Quarter 2024 Financial Results and Highlights Recent Activities • GlobeNewswire Inc. • 11/07/2024 12:30:00 PM
- XOMA Royalty Significantly Expands its Royalty and Milestone Portfolio with the Addition of Over 60 Early-Stage Programs from Twist Bioscience • GlobeNewswire Inc. • 10/22/2024 12:00:00 PM
- Zevra’s MIPLYFFA™ (arimoclomol) Receives Approval from U.S. Food and Drug Administration for Use in Patients with Niemann-Pick Disease Type C (NPC) • GlobeNewswire Inc. • 09/23/2024 10:30:00 AM
- XOMA Royalty Declares Quarterly Preferred Stock Dividends • GlobeNewswire Inc. • 09/23/2024 09:30:00 AM
- XOMA Royalty to Present at Upcoming Investor Conferences in September • GlobeNewswire Inc. • 09/04/2024 11:30:00 AM
- XOMA Royalty Reports Second Quarter 2024 Financial Results and Highlights Recent Activities • GlobeNewswire Inc. • 08/13/2024 11:30:00 AM
A New Mining Model Built for Speed, Scale and Profit • AGI • Jul 17, 2025 9:00 AM
Rainmaker Announces Successful Deployment of Another Fully Containerized Seawater to Tap System in Turks and Caicos • RAKR • Jul 17, 2025 8:40 AM
Fifty 1 Labs, Inc. (FITY) Sparks AI Breakthrough in Drug Repurposing: Subsidiary Fifty1 AI Labs Announces Strategic Partnership with Intent to Acquire BioSpark AI Technologies • FITY • Jul 17, 2025 8:30 AM
A New Mining Model Is Emerging - And Wall Street Is Paying Attention • B • Jul 15, 2025 9:00 AM
Sanwire Files Complaint Against Intercept Music and Trillium Partners • SNWR • Jul 15, 2025 9:00 AM
Cannabix Technologies Commences First Production of BreathLogix Alcohol Screening Devices • BLO • Jul 15, 2025 8:47 AM